Header Logo

Connection

Philip Comp to Female

Back to Details
This is a "connection" page, showing publications Philip Comp has written about Female.
Philip Comp
Connection Strength
0.258
Female
  1. Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant. Blood Coagul Fibrinolysis. 2006 Oct; 17(7):599-602.
    View in: PubMed
    Score: 0.022
  2. Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis? Contraception. 2006 Jan; 73(1):4-5.
    View in: PubMed
    Score: 0.020
  3. A comparison of danaparoid and warfarin for prophylaxis against deep vein thrombosis after total hip replacement: The Danaparoid Hip Arthroplasty Investigators Group. Orthopedics. 1998 Oct; 21(10):1123-8.
    View in: PubMed
    Score: 0.012
  4. Activated factor VII levels in patients with angiographically confirmed coronary artery disease. Am J Cardiol. 1997 Jul 15; 80(2):217-9.
    View in: PubMed
    Score: 0.011
  5. Thrombophilic mechanisms of OCs. Int J Fertil Womens Med. 1997; Suppl 1:170-6.
    View in: PubMed
    Score: 0.011
  6. Monitoring low-dose warfarin therapy by a central laboratory and implications for clinical trials and patient care. The Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1996 Nov 01; 78(9):1074-6.
    View in: PubMed
    Score: 0.011
  7. Fibrinogen levels in women having coronary angiography. Am J Cardiol. 1996 Jul 01; 78(1):15-8.
    View in: PubMed
    Score: 0.011
  8. Prospective evaluation of protein C and factor VIII in prediction of cancer-associated thrombosis. Thromb Res. 2015 Dec; 136(6):1120-5.
    View in: PubMed
    Score: 0.010
  9. Effect of treatment with low-dose warfarin-aspirin on activated factor VII. Blood. 1995 Jun 01; 85(11):3034-9.
    View in: PubMed
    Score: 0.010
  10. Contraceptive choices in women with coagulation disorders. Am J Obstet Gynecol. 1993 Jun; 168(6 Pt 2):1990-3.
    View in: PubMed
    Score: 0.009
  11. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993 Feb 01; 81(3):734-44.
    View in: PubMed
    Score: 0.008
  12. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Am J Obstet Gynecol. 1992 Oct; 167(4 Pt 2):1184-91.
    View in: PubMed
    Score: 0.008
  13. Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study. Thromb Res. 2012 Sep; 130(3):381-9.
    View in: PubMed
    Score: 0.008
  14. Free protein S levels are elevated in familial C4b-binding protein deficiency. Blood. 1990 Dec 15; 76(12):2527-9.
    View in: PubMed
    Score: 0.007
  15. Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery. J Arthroplasty. 2009 Jan; 24(1):1-9.
    View in: PubMed
    Score: 0.006
  16. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. J Thromb Haemost. 2007 Sep; 5(9):1854-61.
    View in: PubMed
    Score: 0.006
  17. The relationship between arterial elasticity and metabolic syndrome features. Angiology. 2007 Feb-Mar; 58(1):5-10.
    View in: PubMed
    Score: 0.006
  18. Oral contraceptives and gender affect protein S status. Blood. 1987 Feb; 69(2):692-4.
    View in: PubMed
    Score: 0.006
  19. Clinical implications of the protein C/protein S system. Ann N Y Acad Sci. 1987; 509:149-55.
    View in: PubMed
    Score: 0.005
  20. Functional and immunologic protein S levels are decreased during pregnancy. Blood. 1986 Oct; 68(4):881-5.
    View in: PubMed
    Score: 0.005
  21. The regulation of hemostasis: the protein C system. N Engl J Med. 1986 May 15; 314(20):1298-304.
    View in: PubMed
    Score: 0.005
  22. Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty. J Bone Joint Surg Am. 2005 Oct; 87(10):2169-77.
    View in: PubMed
    Score: 0.005
  23. Dose-response study of recombinant human soluble thrombomodulin (ART-123) in the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost. 2005 May; 3(5):962-8.
    View in: PubMed
    Score: 0.005
  24. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med. 1984 Dec 13; 311(24):1525-8.
    View in: PubMed
    Score: 0.005
  25. Familial protein S deficiency is associated with recurrent thrombosis. J Clin Invest. 1984 Dec; 74(6):2082-8.
    View in: PubMed
    Score: 0.005
  26. Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement. N Engl J Med. 2003 Oct 30; 349(18):1703-12.
    View in: PubMed
    Score: 0.004
  27. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study. Vasc Endovascular Surg. 2002 Mar-Apr; 36(2):83-91.
    View in: PubMed
    Score: 0.004
  28. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation. 2001 Jul 03; 104(1):74-8.
    View in: PubMed
    Score: 0.004
  29. Predictive value of compression ultrasonography for deep vein thrombosis in symptomatic outpatients: clinical implications of the site of vein noncompressibility. Arch Intern Med. 2000 Feb 14; 160(3):309-13.
    View in: PubMed
    Score: 0.003
  30. Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis. J Rheumatol. 2000 Feb; 27(2):384-90.
    View in: PubMed
    Score: 0.003
  31. Hyperhomocysteinemia, aortic thrombus, and peripheral arterial emboli--a case report. Angiology. 1999 Jul; 50(7):599-603.
    View in: PubMed
    Score: 0.003
  32. The dilute whole blood clot lysis assay: a screening method for identifying postoperative patients with a high incidence of deep venous thrombosis. J Lab Clin Med. 1979 Jan; 93(1):120-7.
    View in: PubMed
    Score: 0.003
  33. The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med. 1998 Jan 01; 128(1):1-7.
    View in: PubMed
    Score: 0.003
  34. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost. 1998; 24(2):195-202.
    View in: PubMed
    Score: 0.003
  35. Selective removal of plasma low density lipoprotein with the HELP system: biweekly versus weekly therapy. Atherosclerosis. 1995 Apr 24; 114(2):203-11.
    View in: PubMed
    Score: 0.002
  36. Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. Am J Cardiol. 1994 Oct 01; 74(7):657-61.
    View in: PubMed
    Score: 0.002
  37. Weekly treatment of diet/drug-resistant hypercholesterolemia with the heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) system by selective plasma low-density lipoprotein removal. Am J Cardiol. 1993 Apr 01; 71(10):816-22.
    View in: PubMed
    Score: 0.002
  38. Afibrinogenemia and hypobetalipoproteinemia in a kindred. Arch Intern Med. 1991 Apr; 151(4):800-4.
    View in: PubMed
    Score: 0.002
  39. Biochemical and physiological aspects of protein c. Ric Clin Lab. 1984 Jul-Sep; 14(3):455-68.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.